Remove Biochemical Assays Remove Biophysical Assays Remove Compound Screening Remove Small Molecule
article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. For fragment screening, which are much smaller compounds, we have a library of about 3000 fragments.